Hikal Q2 FY25 revenue stood at Rs. 453 Cr
Shilpa Medicare’s acceptance by USFDA of NDA filed by its CDMO partner Unicycive for Oxylanthanum Carbonate
Divyesh Maru appointed CFO of Hester Biosciences
EMA grants GMP Certificate of compliance to CuraTeQ biosimilars’ Hyderabad facility
Suven Pharmaceuticals Q2 FY25 revenue grows 12% in Q2
Cupid Q2 FY25 income up 29.7%; PAT up 96.2%
Orchid Pharma Q2 FY25 PAT up 26% YoY driven by strategic initiatives for market expansion
USFDA classifies Biocon Biologics’ Biocon Park in Bengaluru as VAI
Pfizer INDovation program boosts six start-ups with Rs. 1.5 crore grant
Akums Drugs and Pharmaceuticals posts Q2 FY25 adjusted PAT at Rs. 66.7 Cr
Construction of the plant will commence in 2025 with first production expected to be in 2027
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes